Document is current
Any future updates will be listed below
-
Authors
DiLisio, James E. https://orcid.org/0000-0001-9216-0375
Beard, K. Scott
Neef, Tobias
Miller, Stephen D. https://orcid.org/0000-0002-9556-0718
Wenzlau, Janet M.
Nakayama, Maki
D’Antonio, Marc A.
Jamison, Braxton L.
Nicholson, Kelli S.
Baker, Rocky L. https://orcid.org/0000-0001-8361-8655
Brunetti, Tonya M.
Gapin, Laurent https://orcid.org/0000-0001-9730-5174
Haskins, Kathryn https://orcid.org/0000-0002-5430-6254
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK081166)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (F31-AI181452)
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 3 March 2026
First Online: 24 March 2026
Competing interests
: SDM is a cofounder, member of the scientific advisory board, a paid consultant, grantee, and holds stock in Cour Pharmaceuticals Development Company; a paid consultant and member of the scientific advisory board of NextCure, Inc.; and a paid consultant for Takeda Pharmaceuticals International Co. No other authors reported conflicts of interest.
